Executive Assistant, Clinical Development
Alnylam Pharmaceuticals | |
United States, Massachusetts, Cambridge | |
675 West Kendall Street (Show on map) | |
Feb 05, 2025 | |
This role is considered Hybrid.
Overview The Executive Assistant provides consistent, high-level general administrative and project management support to several leaders within Development. This role will report to the Senior Vice President (SVP), Data Science, Statistics & Epidemiology and provide support to other Vice President (VP) leaders (e.g. VP Biostatistics, VP Global Safety Operations). This individual will be responsible for acting as a professional liaison with internal executives and leaders and high-level external contacts. The Executive Assistant coordinates across departments and provides consistent, detailed support to SVP/VPs and respective teams. The Executive Assistant works with other administrative staff across the company to ensure that all project and administrative needs of the department and larger organization are met and support company objectives. The Executive Assistant has strong Microsoft office skills and excels in project management, communication and creative problem solving. The Executive Assistant is distinguished by their ability to organize work, establish priorities, and meet individual and team goals. It is expected that the Executive Assistant will be a highly effective collaborator and communicator, have a positive attitude and demonstrate a proven track record of working with executive leadership. This position is hybrid and will be primarily located in Cambridge, MA. Key Responsibilities
Qualifications
About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. > |